methamphetamine has been researched along with cholecystokinin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, S; Takashima, A | 1 |
| Honda, K; Kamiya, H; Kamiya, Y; Takano, Y; Takeda, Y | 1 |
| Itoh, S; Katsuura, G | 1 |
| Kuribara, H | 1 |
| Lin, JC; Perng, SL; Tsao, WL; Wang, Y | 1 |
| Kunishima, C; Nabeshima, T; Shibuya, H; Toru, M; Yamada, K; Yoshikawa, T | 1 |
| Fukamauchi, F | 1 |
| Angulo, JA; Zhang, Y | 1 |
| Baba, A; Hasegawa, E; Kawai, N; Moroji, T; Ogunremi, OO; Suzuki, T; Takamatsu, Y; Yamamoto, H | 1 |
| Angulo, JA; Loonam, TM; Noailles, PA; Yu, J; Zhu, JP | 1 |
| Cong, B; Gou, H; Li, M; Li, Y; Liu, L; Ma, C; Wen, D; Zhang, W | 1 |
| An, M; Cong, B; Gou, H; Liu, L; Liu, X; Ma, C; Wen, D | 1 |
| An, M; Cong, B; Gou, H; Hao, L; Ma, C; Sun, D; Wen, D; Xie, B | 1 |
1 review(s) available for methamphetamine and cholecystokinin
| Article | Year |
|---|---|
Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum.
Topics: Animals; Cholecystokinin; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Methamphetamine; Mice; Nerve Tissue Proteins; Neurokinin-1 Receptor Antagonists; Rats; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Substance P | 2003 |
12 other study(ies) available for methamphetamine and cholecystokinin
| Article | Year |
|---|---|
Neuropharmacological properties of V-9-M, a putative neuropeptide derived from procholecystokinin, in the rat.
Topics: Animals; Apomorphine; Behavior, Animal; Body Temperature; Cholecystokinin; Eating; Injections, Intraventricular; Male; Methamphetamine; Motor Activity; Nervous System; Pentobarbital; Peptide Fragments; Protein Precursors; Rats; Rats, Inbred Strains; Sleep; Thyrotropin-Releasing Hormone | 1989 |
Effect of injection of CCK-8 into the nucleus caudatus on the behavior of rats.
Topics: Action Potentials; Animals; Behavior, Animal; Catecholamines; Caudate Nucleus; Cholecystokinin; Dopamine; Injections; Male; Methamphetamine; Motor Activity; Rats; Rats, Inbred Strains; Stereotyped Behavior; Time Factors | 1986 |
Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
Topics: Animals; Behavior, Animal; Brain; Ceruletide; Cholecystokinin; Dose-Response Relationship, Drug; Ethanol; Hypnotics and Sedatives; Male; Methamphetamine; Motor Activity; Pentobarbital; Peptide Fragments; Rats; Rats, Inbred Strains; Sincalide; Sleep; Thyrotropin-Releasing Hormone | 1982 |
Contrasting effects on methamphetamine sensitization of ceruletide, a cholecystokinin-like decapeptide, and haloperidol.
Topics: Animals; Behavior, Animal; Ceruletide; Cholecystokinin; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Time Factors | 1995 |
Cholecystokinin facilitates methamphetamine-induced dopamine overflow in rat striatum and fetal ventral mesencephalic grafts.
Topics: Animals; Caudate Nucleus; Cholecystokinin; Corpus Striatum; Dopamine; Drug Synergism; Electrochemistry; Fetal Tissue Transplantation; Medial Forebrain Bundle; Mesencephalon; Methamphetamine; Oxidopamine; Rats; Rats, Sprague-Dawley; Reference Values | 1994 |
Effect of a single injection of psychoactive drugs on CCK mRNA in rat brain.
Topics: Animals; Brain Chemistry; Cholecystokinin; Disease Models, Animal; Male; Methamphetamine; Phencyclidine; Psychoses, Substance-Induced; Rats; Rats, Wistar; RNA, Messenger | 1994 |
Changes in cholecystokinin mRNA expression in methamphetamine-induced behavioral sensitization.
Topics: Animals; Blotting, Northern; Brain; Cholecystokinin; DNA Probes; Frontal Lobe; Hippocampus; Male; Methamphetamine; Octreotide; Rats; Rats, Wistar; RNA, Messenger; Stereotyped Behavior; Transcription, Genetic | 1996 |
Contrasting effects of repeated treatment vs. withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA levels in the ventral tegmental area and substantia nigra zona compacta of the rat brain.
Topics: Animals; Brain Chemistry; Cholecystokinin; Dopamine Uptake Inhibitors; In Situ Hybridization; Male; Methamphetamine; Oligonucleotide Probes; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance Withdrawal Syndrome; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 1996 |
Effect of methamphetamine and dopamine receptor antagonists on cholecystokininlike immunoreactivity in the rat medial prefrontal cortex.
Topics: Animals; Behavior, Animal; Cholecystokinin; Dopamine Antagonists; Male; Methamphetamine; Prefrontal Cortex; Rats; Rats, Wistar | 1997 |
Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
Topics: Amphetamine-Related Disorders; Animals; Body Temperature; Cholecystokinin; Corpus Striatum; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Male; Methamphetamine; Mice, Inbred C57BL; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; Peptide Fragments; Random Allocation; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase | 2015 |
Cholecystokinin-8 inhibits methamphetamine-induced neurotoxicity via an anti-oxidative stress pathway.
Topics: Animals; Cell Survival; Central Nervous System Stimulants; Chemokines, CC; Cholecystokinin; Gene Expression Regulation; HEK293 Cells; Humans; Malondialdehyde; Methamphetamine; NADPH Oxidases; Oxidative Stress; PC12 Cells; Peptide Fragments; Rats; Reactive Oxygen Species; Receptor, Cholecystokinin B; RNA, Small Interfering; Signal Transduction; Time Factors; Transfection | 2016 |
Cholecystokinin-8 attenuates methamphetamine-induced inflammatory activation of microglial cells through CCK2 receptor.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Central Nervous System Stimulants; Cholecystokinin; Inflammation Mediators; Interleukin-6; Methamphetamine; Mice; Microglia; NF-kappa B; Peptide Fragments; Receptor, Cholecystokinin B; Signal Transduction; Tumor Necrosis Factor-alpha | 2020 |